EA200501821A1 - Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат - Google Patents

Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат

Info

Publication number
EA200501821A1
EA200501821A1 EA200501821A EA200501821A EA200501821A1 EA 200501821 A1 EA200501821 A1 EA 200501821A1 EA 200501821 A EA200501821 A EA 200501821A EA 200501821 A EA200501821 A EA 200501821A EA 200501821 A1 EA200501821 A1 EA 200501821A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical combination
drug preparation
containing modafinil
modafinil
drug
Prior art date
Application number
EA200501821A
Other languages
English (en)
Inventor
Родни Дж. Хьюз
Джеффри Л. Вот
Original Assignee
Сефалон, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сефалон, Инк. filed Critical Сефалон, Инк.
Publication of EA200501821A1 publication Critical patent/EA200501821A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Abstract

Композиции и способы лечения заболеваний путем введения модафинила вместе с М-препаратами.
EA200501821A 2003-05-16 2004-05-17 Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат EA200501821A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47130203P 2003-05-16 2003-05-16
US10/845,836 US20040229943A1 (en) 2003-05-16 2004-05-14 Analeptic and drug combinations
PCT/US2004/015408 WO2004103359A1 (en) 2003-05-16 2004-05-17 Pharmaceutical combination comprising modafinil and another drug

Publications (1)

Publication Number Publication Date
EA200501821A1 true EA200501821A1 (ru) 2006-06-30

Family

ID=33424098

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200501821A EA200501821A1 (ru) 2003-05-16 2004-05-17 Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат

Country Status (14)

Country Link
US (1) US20040229943A1 (ru)
EP (1) EP1635807A1 (ru)
JP (1) JP2007506801A (ru)
KR (1) KR20060015727A (ru)
AU (1) AU2004241110A1 (ru)
BR (1) BRPI0411176A (ru)
CA (1) CA2524870A1 (ru)
EA (1) EA200501821A1 (ru)
IS (1) IS8099A (ru)
MX (1) MXPA05012358A (ru)
MY (1) MY135829A (ru)
NO (1) NO20055173L (ru)
TW (1) TW200509896A (ru)
WO (1) WO2004103359A1 (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1309547T3 (da) * 2000-07-27 2007-05-21 Teva Pharma Krystallinsk og ren modafinil og fremgangsmåde til fremstilling af samme
US20070053976A1 (en) * 2002-05-17 2007-03-08 Eisai R & D Management Co., Ltd. Novel combination of drugs as antidepressant
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
WO2005099822A2 (en) * 2004-04-13 2005-10-27 Cephalon, Inc. Reduction of drug / drug interactions with modafinil
US20090209504A1 (en) * 2006-03-23 2009-08-20 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of Digitalis-Like Compounds in the Treatment of Affective Disorders
DE102006015734A1 (de) * 2006-04-04 2007-10-11 Hermann, Holger Lars, Dr. Kombinationspräparate aus Modafinil, Ritalin und Topiramat und deren Derivaten zur Behandlung von Kokainabhängigkeit und/oder Impulskontrollstörung
US20080131491A1 (en) * 2006-12-01 2008-06-05 Akinori Hanatani Percutaneously absorbable preparation
KR101408454B1 (ko) * 2006-12-01 2014-06-17 닛토덴코 가부시키가이샤 도네페질 함유 접착 제제의 착색을 억제하는 방법 및 도네페질의 친척 물질의 생성량을 감소시키는 방법
CN102046171B (zh) * 2008-05-30 2013-06-19 日东电工株式会社 经皮吸收制剂
WO2009145177A1 (ja) * 2008-05-30 2009-12-03 日東電工株式会社 ドネペジル含有貼付製剤およびその包装体
EP2521546A4 (en) * 2010-01-07 2013-06-26 Vivus Inc TREATMENT OF THE OBSTRUCTIVE SLEEP APNEO SYNDROME COMBINED WITH ANTIBODY ANTIBODY AND AN ADDITIONAL ACTIVE SUBSTANCE
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696153A (en) * 1994-05-16 1997-12-09 Napro Biotherapeutics, Inc. Therapeutic regimen for treating patients
FR2771004B1 (fr) * 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
AU6528400A (en) * 1999-08-23 2001-03-19 David M. Ockert Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
US20010034373A1 (en) * 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function
US6417184B1 (en) * 2000-09-19 2002-07-09 David M. Ockert Triple drug therapy for the treatment and prevention of acute or chronic pain
US20030036555A1 (en) * 2001-08-03 2003-02-20 Boehringer Ingelheim Pharma Kg Pramipexole for the treatment of ADHD
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040229941A1 (en) * 2003-05-13 2004-11-18 Cephalon, Inc. Analeptic and antidepressant combinations
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations

Also Published As

Publication number Publication date
IS8099A (is) 2005-10-27
NO20055173D0 (no) 2005-11-03
MY135829A (en) 2008-07-31
WO2004103359A1 (en) 2004-12-02
TW200509896A (en) 2005-03-16
JP2007506801A (ja) 2007-03-22
KR20060015727A (ko) 2006-02-20
US20040229943A1 (en) 2004-11-18
CA2524870A1 (en) 2004-12-02
EP1635807A1 (en) 2006-03-22
NO20055173L (no) 2005-12-12
BRPI0411176A (pt) 2006-07-18
AU2004241110A1 (en) 2004-12-02
MXPA05012358A (es) 2006-02-02

Similar Documents

Publication Publication Date Title
EA200501821A1 (ru) Фармацевтическая комбинация, содержащая модафинил и другой лекарственный препарат
DE602004027936D1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
CY1116215T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
CY1118179T1 (el) Φαρμακευτικη συνθεση
EA200501849A1 (ru) Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ
MX2007004765A (es) Compuestos y metodos que modulan la actividad de la trombopoyetina.
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
DK1519724T3 (da) Fredericamycin-derivater som lægemidler til behandling af tumorer
CY1112376T1 (el) Παραγωγα 2,3,4,9-τετραϋδρο-1η-καρβαζολης ως ανταγωνιστες του υποδοχεα crth2
EA200601846A1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
EA200401526A1 (ru) Новые соединения и их применение
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
EA200602137A1 (ru) Гидрогелевые препараты интерферона
SE0301653D0 (sv) Novel compounds
DK1654253T3 (da) Substituerede 3-pyrrolidinindolderivater
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
EA200700403A1 (ru) ТРИЦИКЛИЧЕСКИЕ δ-ОПИОИДНЫЕ МОДУЛЯТОРЫ
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
EA200701615A1 (ru) Новые лекарственные средства для лечения заболеваний дыхательных путей
EA200401319A1 (ru) Новые гетероциклические соединения, способы их получения и фармацевтические композиции, содержащие эти соединения, и их использование в медицине
EA200970127A1 (ru) Модулятор рецепторов глюкокортикостероидов и способы его применения
NO20051261L (no) Morfin-6-glukuronidsalt
EA200900269A1 (ru) Лекарственные комбинации для лечения заболеваний дыхательных путей
EA200702136A1 (ru) Композиции станнсопорфина и их применение
EA200500774A1 (ru) Новая синергетическая комбинация, включающая рофлумиласт и формотерол